These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents. Alagumuthu M, Arumugam S. Bioorg Med Chem; 2017 Feb 15; 25(4):1448-1455. PubMed ID: 28094220 [Abstract] [Full Text] [Related]
7. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase. Liu H, Chu ZW, Xia DG, Cao HQ, Lv XH. Bioorg Chem; 2020 Jun 15; 99():103807. PubMed ID: 32272364 [Abstract] [Full Text] [Related]
8. Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin-1,2,4-triazole scaffolds. Pathak P, Novak J, Shukla PK, Grishina M, Potemkin V, Verma A. Arch Pharm (Weinheim); 2021 Jun 15; 354(6):e2000473. PubMed ID: 33656194 [Abstract] [Full Text] [Related]
9. Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies. Ammar YA, Farag AA, Ali AM, Hessein SA, Askar AA, Fayed EA, Elsisi DM, Ragab A. Bioorg Chem; 2020 Jun 15; 99():103841. PubMed ID: 32325335 [Abstract] [Full Text] [Related]
10. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking. Alagumuthu M, Muralidharan VP, Andrew M, Ahmed MH, Iyer SK, Arumugam S. Mol Inform; 2018 Dec 15; 37(12):e1800048. PubMed ID: 30051592 [Abstract] [Full Text] [Related]
11. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV. Hofny HA, Mohamed MFA, Gomaa HAM, Abdel-Aziz SA, Youssif BGM, El-Koussi NA, Aboraia AS. Bioorg Chem; 2021 Jul 15; 112():104920. PubMed ID: 33910078 [Abstract] [Full Text] [Related]
12. Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors. Hashem HE, Amr AEE, Nossier ES, Elsayed EA, Azmy EM. Molecules; 2020 Jun 15; 25(12):. PubMed ID: 32549386 [Abstract] [Full Text] [Related]
13. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity. Hassan AS, Askar AA, Naglah AM, Almehizia AA, Ragab A. Molecules; 2020 Jun 02; 25(11):. PubMed ID: 32498469 [Abstract] [Full Text] [Related]
14. Targeted potent antimicrobial benzochromene-based analogues: Synthesis, computational studies, and inhibitory effect against 14α-Demethylase and DNA Gyrase. Fouda AM, Hassan AH, Eliwa EM, Ahmed HEA, Al-Dies AM, Omar AM, Nassar HS, Halawa AH, Aljuhani N, El-Agrody AM. Bioorg Chem; 2020 Dec 02; 105():104387. PubMed ID: 33130344 [Abstract] [Full Text] [Related]
15. Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors. Salem MA, Ragab A, El-Khalafawy A, Makhlouf AH, Askar AA, Ammar YA. Bioorg Chem; 2020 Mar 02; 96():103619. PubMed ID: 32036161 [Abstract] [Full Text] [Related]
16. Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective. Ponnusamy T, Alagumuthu M, Thamaraiselvi S. Bioorg Med Chem; 2018 Jul 23; 26(12):3438-3452. PubMed ID: 29803359 [Abstract] [Full Text] [Related]
17. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors. Durcik M, Tammela P, Barančoková M, Tomašič T, Ilaš J, Kikelj D, Zidar N. ChemMedChem; 2018 Jan 22; 13(2):186-198. PubMed ID: 29206345 [Abstract] [Full Text] [Related]
18. Development of fluorinated nicotinonitriles and fused candidates as antimicrobial, antibiofilm, and enzyme inhibitors. Ibrahim MH, El Menofy NG, El Kiki SM, Sherbiny FF, Ismail MMF. Arch Pharm (Weinheim); 2022 Jul 22; 355(7):e2200040. PubMed ID: 35411641 [Abstract] [Full Text] [Related]
20. One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor. Salem MA, Ragab A, Askar AA, El-Khalafawy A, Makhlouf AH. Eur J Med Chem; 2020 Feb 15; 188():111977. PubMed ID: 31927313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]